Fabio Fachin

Head of Cell Therapy Process Development, Automation and Digital Technologies • Takeda

Fabio Fachin, PhD, is the Head of Cell Therapy Process Development, Automation and Digital Technologies at Takeda, a company focusing on off-the-shelf, allogeneic cell therapies targeting both solid tumors and hematological malignancies. Prior to Takeda, Dr. Fachin was at Novartis where he contributed to the development of Kymriah, and at Torque Therapeutics where he was VP of Cell Therapy Development and Manufacturing. Dr. Fachin holds a PhD in Aerospace Engineering from the Massachusetts Institute of Technology, and a Post-Doctoral Fellowship from Harvard Medical School. His early career was in the aerospace sector, developing micro-technologies for aircraft and satellite guidance.

Also Speaking

John Campbell

Director, Tissues, Cells & Advanced Therapeutics • Scottish National Blood & Transplant Service

Samik Basu

Chief Scientific Officer • Cabaletta Bio

Najib Rehman

Digital Automation Lead • ATMPS

Event Info


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.